Electra Therapeutics (ETRA) IPO deck
Electra Therapeutics is a late clinical-stage biotechnology company developing SIRP-targeted antibodies to selectively deplete disease-driving immune cells in severe immunological disorders and cancer.
Electra Therapeutics is a late clinical-stage biotechnology company developing SIRP-targeted antibodies to selectively deplete disease-driving immune cells in severe immunological disorders and cancer.
%20IPO%20deck){kind=link}